» Articles » PMID: 7843706

Single Photon Emission Computed Tomography to Determine Effective Hepatic Blood Flow and Intrahepatic Shunting

Overview
Journal Hepatology
Specialty Gastroenterology
Date 1995 Feb 1
PMID 7843706
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The noninvasive determination of effective hepatic blood flow, intrahepatic shunted blood flow, intrahepatic shunt index, and total hepatic blood flow was investigated by using the sequential single photon emission computed tomography. This method was performed for a period of 10 minutes following an intravenous injection of 99mTc-(Sn)-N-pyridoxyl-5-methyltryptophan and a venous blood sampling. This study comprised 8 healthy volunteers, 16 patients with chronic hepatitis, and 33 patients with liver cirrhosis. The intrahepatic shunt index measured with this method coincided with the intrahepatic shunt index determined by catheterization, indicating the high reliability of this procedure. The effective hepatic blood flow in patients with liver cirrhosis was significantly lower than that in the healthy controls and the chronic hepatitis group. The intrahepatic shunted blood flow was significantly higher in patients with liver cirrhosis compared with the flow in healthy controls. The intrahepatic shunt index was also significantly higher in patients with liver cirrhosis compared with the index of healthy controls and those with chronic hepatitis. No substantial differences were noted in the total hepatic blood flow among the three groups. The effective hepatic blood flow, the intrahepatic shunted blood flow, and the intrahepatic shunt index, correlated with the serum albumin concentration, the serum cholinesterase level, and the plasma indocyanine green attenuation rate. From these results, it was concluded that the present procedure constitutes a reliable and effective method for the noninvasive determination of hepatic blood flows. Consequently, it will be of high clinical value for assessing the functional and the pathological alterations of the liver.

Citing Articles

Use of Caval Subtraction 2D Phase-Contrast MR Imaging to Measure Total Liver and Hepatic Arterial Blood Flow: Preclinical Validation and Initial Clinical Translation.

Chouhan M, Mookerjee R, Bainbridge A, Walker-Samuel S, Davies N, Halligan S Radiology. 2016; 280(3):916-23.

PMID: 27171018 PMC: 5015842. DOI: 10.1148/radiol.2016151832.


Investigation on the optimal position for the quantification of hepatic perfusion by use of dynamic contrast-enhanced computed tomography in rats.

Miyazaki S, Tachibana A, Kitamura A, Nagasawa A, Yamazaki Y, Murase K Radiol Phys Technol. 2010; 2(2):183-8.

PMID: 20821118 DOI: 10.1007/s12194-009-0063-4.


Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography.

Chen M, Zeng Q, Huo J, Yin X, Li B, Liu J World J Gastroenterol. 2009; 15(28):3532-7.

PMID: 19630110 PMC: 2715981. DOI: 10.3748/wjg.15.3532.


The portal component of hepatic perfusion measured by dynamic CT: an indicator of hepatic parenchymal damage.

Tsushima Y, Blomley J, Kusano S, Endo K Dig Dis Sci. 1999; 44(8):1632-8.

PMID: 10492145 DOI: 10.1023/a:1026679430553.


Quantitative analysis of scatter- and attenuation-compensated dynamic single-photon emission tomography for functional hepatic imaging with a receptor-binding radiopharmaceutical.

Ichihara T, Maeda H, Yamakado K, Motomura N, Matsumura K, Takeda K Eur J Nucl Med. 1997; 24(1):59-67.

PMID: 9044878 DOI: 10.1007/BF01728310.